[
    "sosomal storage disease (ARSA), hypoxanthine guanine phosphoribosyl transferase, P-25 glucocerebrosidase, sphingomyelinase, lysosomal hexosaminidase, branched chain keto acid dehydrogenase, a hormone, a growth factor, insulin-like growth factor 1 or 2, platelet derived growth factor, epidermal growth factor, nerve growth factor, neurotrophic factor-3 and -4, brain-derived neurotrophic factor, glial derived growth factor, transforming growth factor \u03b1 and \u03b2, a cytokine, interferon-\u03b1, interferon-\u03b3, interleukin-2, interleukin-12, granulocyte-macrophage colony stimulating factor, lymphotoxin, a suicide gene product, herpes simplex virus thymidine kinase, cytosine deaminase, diphtheria toxin, cytochrome P450, deoxycytidine kinase, tumor necrosis factor, a drug resistance protein, a tumor suppressor protein (e.g., p53, Rb, Wt-1, NF1, Von Hippel-Lindau (VHL), SERCA2a, adenomatous polyposis coli (APC)), VEGF, microdystrophin, lysosomal acid lipase, arylsulfatase A and B, ATP7A and B, a peptide with immunomodulatory properties, a tolerogenic or immunogenic peptide or protein Tregitope or hCDR1, insulin, glucokinase, guanylate cyclase 2D (LCA-GUCY2D), Rab escort protein 1 (Choroideremia), LCA 5 (LCA-Lebercilin), ornithine ketoacid aminotransferase (Gyrate Atrophy), Retinoschisin 1 (X-linked Retinoschisis), USH1C (Usher's Syndrome IC), X-linked retinitis pigmentosa GTPase (XLRP), MERTK (AR forms of RP: retinitis pigmentosa), DFNB1 (Connexin 26 deafness), ACHM 2, 3 and 4 (Achromatopsia), PKD-1 or PKD-2 (Polycystic kidney disease), TPP1, CLN2, a gene product implicated in lysosomal storage diseases (e.g., sulfatases, N-acetylglucosamine-1-phosphate transferase, cathepsin A, GM2-AP, NPC1, VPC2, a sphingolipid activator protein), or one or more zinc finger nucleases, transcription activation-like effector nucleases (TALENs), or CRISPER-Cas9 protein for genome editing, or donor sequences used as repair templates for genome editing, and any other peptide or protein that has a therapeutic effect in an individual in need thereof. Preferably, the therapeutic protein is a therapeutic anti-inflammatory protein, preferably selected from the group consisting of (soluble) cluster of differentiation 39 (CD39) protein, (soluble) cluster of differentiation 73 (CD73) protein, interleukin-1 inhibitor, tumor necrosis factor-\u03b1 inhibitor, interleukin-1 receptor antagonist, interleukin-18 binding protein, soluble tumor necrosis factor-\u03b1 receptor p55 or soluble tumor necrosis factor-\u03b1 protein 75, dominant negative I\u03baB kinase-\u03b2, interleukin-4, interleukin-10, interleukin-13, interferon-\u03b2 and vasoactive intestinal polypeptide.</p>Further exemplary therapeutic peptides or proteins encoded by transgenes include those that may be used in the treatment of a disease or disorder including, but not limited to, rheumatoid arthritis (RA), juvenile rheumatoid arthritis, osteoarthritis (OA), gout, spondlyarthritis (SpA), psoriasis, psoriatic arthritis, ankylosing spondylitis, inflammatory bowel disease "
]